We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$257M
AUM Growth
+$20.3M
Cap. Flow
-$3.38M
Cap. Flow %
-1.32%
Top 10 Hldgs %
33.42%
Holding
167
New
24
Increased
41
Reduced
51
Closed
33

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.37M
2
ULTA icon
Ulta Beauty
ULTA
+$2.18M
3
COP icon
ConocoPhillips
COP
+$2.04M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.97M
5
EMR icon
Emerson Electric
EMR
+$1.81M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$4.77M
2
UBER icon
Uber
UBER
+$3.19M
3
PANW icon
Palo Alto Networks
PANW
+$2.27M
4
CRWD icon
CrowdStrike
CRWD
+$2.23M
5
DHI icon
D.R. Horton
DHI
+$2.13M

Sector Composition

Rank Sector Weight
1 Industrials 24.01%
2 Healthcare 17.6%
3 Financials 14.71%
4 Technology 12.6%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.36T
$14.6M 5.68%
40,825
-525
-1% -$189K
AAPL icon
2
Apple
AAPL
$4.54T
$12M 4.69%
41,639
+3,788
+10% +$1.08M
URI icon
3
United Rentals
URI
$67.2B
$10.4M 4.04%
9,169
-1,902
-17% -$1.81M
PWR icon
4
Quanta Services
PWR
$100B
$10.3M 4.03%
14,367
+2,174
+18% +$1.49M
GEV icon
5
GE Vernova
GEV
$264B
$7.63M 2.97%
6,497
+1,177
+22% +$1.2M
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$7.5M 2.92%
29,527
+714
+2% +$166K
ABBV icon
7
AbbVie
ABBV
$443B
$6.23M 2.43%
24,774
-736
-3% -$158K
MSFT icon
8
Microsoft
MSFT
$3.45T
$5.94M 2.31%
15,927
+919
+6% +$372K
CSX icon
9
CSX Corp
CSX
$93.4B
$5.89M 2.29%
123,926
-2,547
-2% -$115K
V icon
10
Visa
V
$684B
$5.32M 2.07%
15,495
+1,549
+11% +$497K
CHD icon
11
Church & Dwight Co
CHD
$23.4B
$4.86M 1.89%
50,200
-1,350
-3% -$129K
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.61M 1.79%
9,203
-299
-3% -$144K
AMGN icon
13
Amgen
AMGN
$208B
$4.3M 1.67%
11,880
+2,070
+21% +$709K
LLY icon
14
Eli Lilly
LLY
$1.02T
$4.26M 1.66%
3,556
+403
+13% +$412K
AVGO icon
15
Broadcom
AVGO
$1.85T
$4.22M 1.64%
11,176
-195
-2% -$78.2K
AMZN icon
16
Amazon
AMZN
$2.92T
$4.07M 1.58%
17,079
-2,393
-12% -$601K
AWK icon
17
American Water Works
AWK
$26.7B
$3.72M 1.45%
28,277
+5,481
+24% +$704K
UNP icon
18
Union Pacific
UNP
$174B
$3.65M 1.42%
13,403
+4,340
+48% +$1.14M
NFLX icon
19
Netflix
NFLX
$299B
$3.54M 1.38%
49,574
+14,094
+40% +$1.24M
MRK icon
20
Merck
MRK
$322B
$3.51M 1.36%
27,279
+750
+3% +$87.8K
IBM icon
21
IBM
IBM
$211B
$3.48M 1.35%
12,368
+2,353
+23% +$593K
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.36T
$3.4M 1.32%
9,620
-250
-3% -$89.3K
MS icon
23
Morgan Stanley
MS
$331B
$3.02M 1.18%
14,450
+500
+4% +$99K
AZN icon
24
AstraZeneca
AZN
$263B
$3.01M 1.17%
15,893
+12,595
+382% +$2.37M
GS icon
25
Goldman Sachs
GS
$300B
$2.95M 1.15%
2,916
-107
-4% -$104K
1
2 3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2026 Portfolio in Review

As of Q2 2026, New England Research & Management held 167 positions worth $257M, up 8.6% from $237M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

New England Research & Management's Q2 2026 filing shows 24 new, 41 increased, 51 reduced and 33 closed positions. Its largest new stake was Ulta Beauty: 4,303 shares worth $1.94M. The largest sale was Capital One, an estimated $4.77M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2026 buy was Ulta Beauty: 4,303 shares worth $1.94M.
  • New England Research & Management added most to AstraZeneca in Q2 2026, an estimated $2.37M increase.
  • New England Research & Management's biggest Q2 2026 reduction was Idexx Laboratories, cutting an estimated $1.82M.
  • New England Research & Management fully exited Capital One in Q2 2026, selling an estimated $4.77M.
  • New England Research & Management's ten largest holdings make up 33% of its $257M portfolio in Q2 2026.
  • New England Research & Management opened 24 new positions and closed 33 in Q2 2026.
  • New England Research & Management's portfolio value rose 8.6% quarter-over-quarter to $257M.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.